Carisma Therapeutics to Present at March Scientific and Investor Conferences
PHILADELPHIA — Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two conferences in March, 2020.
- Festival of Biologics USA, March 2-4, 2020: Steve Kelly, Chief Executive Officer, will present at the World Immunotherapy Congress on Monday, March 2, 2020, at 3:00 p.m. PST. The congress will be held at the Loews Resort Coronado in San Diego, CA.
- Cowen and Company 40th Annual Healthcare Conference, March 2-4, 2020: Tom Wilton, Chief Business Officer, will present on Tuesday, March 3, 2020, at 5:00 p.m. EST. The conference will be held at the Marriott Copley Place in Boston, MA.
- Immuno-Oncology Summit Europe, March 9-12, 2020: Michael Klichinsky, PhD, Co-Founder and VP, Discovery Research, will deliver a presentation entitled “CAR Macrophage Immunotherapy: A New Frontier for Innate Immunity” on Tuesday, March 10, 2020 at 1:55 p.m. GMT. The summit will be held at the Hilton London Canary Wharf in London, UK.
About Carisma Therapeutics Inc.
Carisma Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.
Media Contact:
Christina Khoury-Folkens
612-806-0757
ckhoury@w2ogroup.com